- 
				Abstract Number: 0132 Hospitalization Rates Among Patients with Systemic Lupus Erythematosus: A Population Based Study
- 
				Abstract Number: 0133 Cervical Cancer Screening Rate in Women with Systemic Lupus Erythematosus
- 
				Abstract Number: 0134 Systemic Lupus Erythematosus Is a Risk Factor for Mortality in Older Patients with Early-Stage Breast Cancer
- 
				Abstract Number: 0135 Comparing Rheumatoid Arthritis (RA), Psoriatic Arthritis (PA) and Systemic Lupus Erythematosus (SLE) Total Cost of Care (TCC) in Those with Optimally Managed Depression to Those with Sub-optimally Managed Depression
- 
				Abstract Number: 0136 Underutilization of Mental Health Services in a Busy Tertiary Care Rheumatology Facility
- 
				Abstract Number: 0137 Antiviral Use and Healthcare Resource Utilization Among Patients with Rheumatoid Arthritis and Influenza in Three Influenza Seasons, 2016–2019
- 
				Abstract Number: 0138 Treatment with Adalimumab in Patients with Chronic Inflammatory Rheumatic Diseases: A Study of Treatment Trajectories on a Patient Level in Clinical Practice
- 
				Abstract Number: 0139 Treatment of Ankylosing Spondylitis by Primary Care Physicians and Rheumatologists in an Academic Health System: A Retrospective Study
- 
				Abstract Number: 0140 Therapeutic Management and Clinical Remission in a Specialized Dermatological-Rheumatological Center for Patients with Psoriasis and Psoriatic Arthritis
- 
				Abstract Number: 0141 Who Gets Influenza Vaccinations Prior to and After a Diagnosis of RA? Results from the Canadian Early Arthritis Cohort (CATCH)
- 
				Abstract Number: 0142 Description of a Scleroderma Cohort and Management of Lung Disease Risk at a Rural Academic Medical Center
- 
				Abstract Number: 0143 Economic and Healthcare Resource Use Burden of Systemic Sclerosis
- 
				Abstract Number: 0144 Healthcare Utilization and Costs Following Kawasaki Disease in Ontario, Canada
- 
				Abstract Number: 0145 Rheumatology Provider Perspectives on Using Patient-Reported Outcomes in Clinical Care
- 
				Abstract Number: 0146 Improving Medication Toxicity Lab Monitoring During the COVID-19 Pandemic
- « Previous Page
- 1
- …
- 10
- 11
- 12
- 13
- 14
- …
- 132
- Next Page »
